Actionable news
All posts from Actionable news
Actionable news in SRPT: Sarepta Therapeutics, Inc.,

Sarepta Therapeutics: Say Hello To The New CEO

When Sarepta Therapeutics (SRPT) unveils its second quarter financial results on July 19, investors will get a gander at more than profits and sales. The after-market conference hosted by the drug maker for analysts and investors will mark the introduction of Douglas Ingram as the new chief executive.

In fact, it will be Wall Street’s first opportunity to hear about “his vision and strategies for the company going forward,” says Joseph P. Schwartz, an analyst at Leerink.

What else can investors expect from Sarepta's earnings conference call? Schwartz offers his thoughts.

With the company’s recent decision...